
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
Expected to be Effective as of Commencement of Trading on August 15, 2025 ReShape Lifesciences has announced that its shareholders have approved all the necessary
Expected to be Effective as of Commencement of Trading on August 15, 2025 ReShape Lifesciences has announced that its shareholders have approved all the necessary
ReShape Enters Exclusive U.S. Distribution Agreement in the Neuromuscular Rehabilitation Market ReShape Lifesciences, the premier physician-led weight loss and metabolic health solutions company, announced that it
Fuel up with free Health Tech Insights